Associated illness severity in schizophrenia and diabetes mellitus: A systematic review
| Autor: | Andrew J. Gibson, Anne Meakin, Daniel Green, Deepali Mahajan, Swaran P. Singh, Tayyeb A. Tahir, Dhanya Salimkumar, Benjamin Ian Perry |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Ovid medline Web of science Severity of Illness Index Type ii diabetes 03 medical and health sciences 0302 clinical medicine Diabetes mellitus Diabetes Mellitus medicine Humans Illness severity Longitudinal Studies Psychiatry Biological Psychiatry business.industry Cognition medicine.disease 030227 psychiatry Observational Studies as Topic Psychiatry and Mental health Schizophrenia Hyperglycemia Observational study business 030217 neurology & neurosurgery RC Clinical psychology |
| Zdroj: | Psychiatry Research. 256:102-110 |
| ISSN: | 0165-1781 |
| DOI: | 10.1016/j.psychres.2017.06.027 |
| Popis: | Objective\ud \ud We aimed to elucidate whether schizophrenia and type II diabetes mellitus may present with associated illness severity, in light of accumulating evidence to suggest both conditions have important shared inflammatory components with many shared inflammatory genetic factors.\ud \ud Methods\ud \ud We conducted a systematic review employing PRISMA criteria, searching EMBASE, Ovid MEDLINE, PsychInfo, Web of Science and Google Scholar to February 1st 2017, for clinical studies assessing schizophrenia severity alongside dysglycaemia. A narrative synthesis was employed to discuss and compare findings between studies.\ud \ud Results\ud \ud Eleven observational studies were included in the analysis. Ten presented evidence in support of an association between schizophrenia severity and dysglycaemia. This association appeared particularly strong regarding negative symptomatology and impaired cognitive function, between which there may be some overlap. Studies examining positive symptomatology returned mixed results.\ud \ud Conclusion\ud \ud Whilst study design varied amongst the included studies, the results suggest that further work examining the effect of hyperglycaemia on schizophrenia severity may be relevant, particularly longitudinal studies assessing negative symptomatology and cognitive function. To the authors’ knowledge, this is the first systematic review conducted to address this question. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect